Natco Pharma Ltd. logo

Natco Pharma Ltd. (NATCOPHARM)

Market Open
8 Dec, 10:29
MSE MSE
898. 80
-34.8
-3.73%
- Market Cap
13.93 P/E Ratio
5% Div Yield
135,203 Volume
0 Eps
933.6
Previous Close
Day Range
892.5 945.75
Year Range
660.05 1,504
Want to track NATCOPHARM and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Earnings results expected in 64 days
Name Time Cons. EPS Eps
Natco Pharma Ltd. logo
NATCOPHARM Natco Pharma Ltd.
12 Feb 2026 (In 2 months)
5.7
-
Natco Pharma Ltd. logo
NATCOPHARM Natco Pharma Ltd.
10 Feb 2026 (In 2 months)
-
-
Natco Pharma Ltd. logo
NATCOPHARM Natco Pharma Ltd.
14 Nov 2025
24.56
28.94
Natco Pharma Ltd. logo
NATCOPHARM Natco Pharma Ltd.
13 Nov 2025
24.56
-
Natco Pharma Ltd. logo
NATCOPHARM Natco Pharma Ltd.
11 Nov 2025
24.56
-
Natco Pharma Ltd. logo
NATCOPHARM Natco Pharma Ltd.
10 Nov 2025
-
-
Natco Pharma Ltd. logo
NATCOPHARM Natco Pharma Ltd.
11 Aug 2025
-
-
Natco Pharma Ltd. logo
NATCOPHARM Natco Pharma Ltd.
12 Feb 2025
13.36
7.43
Natco Pharma Ltd. logo
NATCOPHARM Natco Pharma Ltd.
12 Nov 2024
31.5
37.81
Natco Pharma Ltd. logo
NATCOPHARM Natco Pharma Ltd.
27 Sep 2024
-
-
Natco Pharma Ltd. logo
NATCOPHARM Natco Pharma Ltd.
7 Aug 2024
-
-
Natco Pharma Ltd. logo
NATCOPHARM Natco Pharma Ltd.
27 May 2024
16.01
21.56
Natco Pharma Ltd. logo
NATCOPHARM Natco Pharma Ltd.
7 Feb 2024
-
-
Natco Pharma Ltd. logo
NATCOPHARM Natco Pharma Ltd.
8 Nov 2023
-
-
Natco Pharma Ltd. logo
NATCOPHARM Natco Pharma Ltd.
11 Nov 2016
1.87
3.8
Natco Pharma Ltd. logo
NATCOPHARM Natco Pharma Ltd.
10 Feb 2014
3.44
10.12
Natco Pharma Ltd. logo
NATCOPHARM Natco Pharma Ltd.
14 Nov 2013
9.3
9.34

NATCOPHARM Earnings Reports FAQ

What is the earnings per share (EPS) for NATCOPHARM?

The current EPS is 0.

What is the company's earnings growth rate?

Over the past 12 years, the earnings growth rate has been approximately 28.41%, reflecting the NATCOPHARM's performance and MSE market conditions.

When is the next earnings release date?

The next earnings release is expected to be on 2026-02-10, based on the NATCOPHARM's typical earnings announcement schedule.

What were the most recent quarterly earnings?

The most recent quarterly earnings were 28.94 per share, reported on 2025-11-14. For dividend history, visit the NATCOPHARM Dividends page.

What is the price-to-earnings (P/E) ratio?

The price-to-earnings (P/E) ratio is 31.06, calculated based on the most recent stock price of ₹898.80.